Stockreport

Ocular Therapeutix announces accelerated timelines for trial of AXPAXLI in wet AMD [Seeking Alpha]

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com
PDF The company now expects the SOL-1 study to be fully enrolled with all patients randomized by the end of With this update, topline data from the SOL-1 trial are now ex [Read more]